Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

JANUARY 4, 2022

Gold Leaf is one of only 22 licensed centers and one of only 16 active operators in Florida, and the organization is planning to open 20 dispensaries in the state by 2024. Agrify brings data, science, and technology to its customers for unparalleled control over cultivation and extraction. BILLERICA, Mass.,

Extraction 52

Extraction Cultivation Programs Data 52

Cannabis Law Report

DECEMBER 2, 2021

Practicum training is a major focus of the proposed training curriculum, and as the program matures, students will observe and facilitate psilocybin treatment sessions under the supervision of a Practicum Site Supervisor. Programs shall train students on how to proactively make psilocybin services accessible to people with disabilities.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Cannabis Law Report

JANUARY 9, 2022

Of the cannabis-related tax revenue it collects, the state distributes 40% to public schools, 15% to law enforcement, and 25% to mental health and treatment programs. Sales are scheduled to begin in January 2024, but the legislature could speed up — or stall — implementation. The state’s medical patients (about 0.5% Arizona (pop.

Collective 52

Collective Policy Retail Programs 52